C.F.R. homeSearch C.F.R.
C.F.R.Title 42Chapter IV—Centers for Medicare & Medicaid Services, Department of Health and Human ServicesSubchapter C—Medical Assistance ProgramsPart 447—Payments for ServicesSubpart I—Payment for Drugs

42 C.F.R. § 447.500 (2026)

Basis and purpose

Edition and currency
eCFR text as of Sept. 29, 2026. The text is the edition Syfert holds; for a past event, check the version in force on that date.
Other sources
CURRENTeCFR text as of Sept. 29, 2026 ACTIVE · 6 IN 5Y cited 2014–2025 9citing cases
At a glance

Courts have cited this section in 9 opinions since 2014, 6 of them in the last five years.

(a) Basis. This subpart:

(1) Interprets those provisions of section 1927 of the Act that set forth requirements for drug manufacturers' calculating and reporting average manufacturer prices (AMPs) and best prices and that set upper payment limits for covered outpatient drugs.

(2) Implements section 1903(i)(10) of the Act with regard to the denial of Federal financial participation (FFP) in expenditures for certain physician-administered drugs.

(3) Implements section 1902(a)(54) of the Act with regard to a State plan that provides covered outpatient drugs.

(4) Implements section 1903(m)(2)(A)(xiii) of the Act, in part, and section 1927(b) of the Act with regard to rebates for covered outpatient drugs dispensed to individuals eligible for medical assistance who are enrolled in Medicaid managed care organizations (MCOs).

(5) Implements section 1902(a)(30)(A) of the Act with regard to the efficiency, economy, and quality of care in the context of payments for covered outpatient drugs.

(b) Purpose. This subpart specifies certain requirements in the Social Security Act, including changes from the Affordable Care Act and other requirements pertaining to Medicaid payment for drugs.

The 9 cases that cite 42 C.F.R. § 447.500 most heavily, weighted by court and treatment. RelevanceNewestTreatment
1
GREENUnited States ex rel. Streck v. Bristol-Myers Squibb Co., 370 F. Supp. 3d 491 (E.D. Pa. 2019).
cites § 447.500 1×cited by 14 cases
Where it cites § 447.500
“" 42 C.F.R. § 447.500 (b). Relator's Resp. to Mot.”
Later courts cite it for
“(1) the defendant presented a claim for payment to the united states; (2) the claim was false; (3) the defendant knew the claim was false; and (4) the false statement was material to the decision.” · 2 citing courts
cites § 447.500 1×cited by 18 cases
Where it cites § 447.500
“§ 1396r-8 (2012) (providing requirements for prescription drug reimbursements); see also 42 C.F.R. § 447.500 through 447.520 (2012) (providing regulations for payments for prescription drugs).”
Later courts cite it for
“new mexico courts have long honored the statutory command that the text of a statute or rule is the primary, essential source of its meaning through application of the plain meaning rule, recognizing that when a statute contains language which is clear and unambiguous, we must give effect to that language and refrain from further statutory interpretation.” · 3 citing courts
3
NO FLAGStarko, Inc. v. New Mexico Human Servs. Dep't, 2014-NMSC-033, 6 N.M. 590.
cites § 447.500 2×cited by 1 case
Where it cites § 447.500
“§ 1396r-8 (2012) (providing requirements for prescription drug reimbursements); see also 42 C.F.R. § 447.500 through 447.520 (2012) (providing regulations for payments for prescription drugs).”
4
NO FLAGRonald Streck v. Eli Lilly & Co., No. 24-1884 (7th Cir. Sept. 11, 2025).
cites § 447.500 1×cited by 0 cases
Where it cites § 447.500
“39,142 (July 17, 2007) (codified at 42 C.F.R. §447.500 et seq.). Manu- facturers could exclude “fees paid by a manufacturer to an entity” (such as a wholesaler) “for a bona fide, itemized ser- vice actually performed on behalf of the manufacturer that the manufacturer would…”
5
NO FLAGRonald Streck v. Eli Lilly & Co., No. 24-1352 (7th Cir. Sept. 11, 2025).
cites § 447.500 1×cited by 0 cases
Where it cites § 447.500
“39,142 (July 17, 2007) (codified at 42 C.F.R. §447.500 et seq.). Manu- facturers could exclude “fees paid by a manufacturer to an entity” (such as a wholesaler) “for a bona fide, itemized ser- vice actually performed on behalf of the manufacturer that the manufacturer would…”
6
NO FLAGRonald Streck v. Eli Lilly & Co., No. 23-3035 (7th Cir. Sept. 11, 2025).
cites § 447.500 1×cited by 0 cases
Where it cites § 447.500
“39,142 (July 17, 2007) (codified at 42 C.F.R. §447.500 et seq.). Manu- facturers could exclude “fees paid by a manufacturer to an entity” (such as a wholesaler) “for a bona fide, itemized ser- vice actually performed on behalf of the manufacturer that the manufacturer would…”
7
NO FLAGRonald J. Streck v. Eli Lilly & Co., No. 23-2958 (7th Cir. Sept. 11, 2025).
cites § 447.500 1×cited by 0 cases
Where it cites § 447.500
“39,142 (July 17, 2007) (codified at 42 C.F.R. §447.500 et seq.). Manu- facturers could exclude “fees paid by a manufacturer to an entity” (such as a wholesaler) “for a bona fide, itemized ser- vice actually performed on behalf of the manufacturer that the manufacturer would…”
8
NO FLAGRonald J. Streck v. Eli Lilly & Co., No. 23-2216 (7th Cir. Sept. 11, 2025).
cites § 447.500 1×cited by 0 cases
Where it cites § 447.500
“39,142 (July 17, 2007) (codified at 42 C.F.R. §447.500 et seq.). Manu- facturers could exclude “fees paid by a manufacturer to an entity” (such as a wholesaler) “for a bona fide, itemized ser- vice actually performed on behalf of the manufacturer that the manufacturer would…”
9
NO FLAGRonald J. Streck v. Eli Lilly & Co., No. 23-2134 (7th Cir. Sept. 11, 2025).
cites § 447.500 1×cited by 0 cases
Where it cites § 447.500
“39,142 (July 17, 2007) (codified at 42 C.F.R. §447.500 et seq.). Manu- facturers could exclude “fees paid by a manufacturer to an entity” (such as a wholesaler) “for a bona fide, itemized ser- vice actually performed on behalf of the manufacturer that the manufacturer would…”

The flag is Syfertize’s treatment of the citing case itself, not of the statute. “Where it cites” is the passage in the opinion; the holding is a summary of the whole case and may concern another point. Annotations are extracted automatically from the opinions in the Syfert caselaw corpus.

Citing cases by year
201420192025

One bar per year. Tallest: 6 cases in 2025. These are opinions in the Syfert collection, which holds more of some courts’ recent opinions than their older ones, so a rise can reflect what the collection holds and not more litigation.

By court
7th Cir.6N.M.2E.D. Pa.1
By subsection

Courts have not cited this section by subsection, so its cases are not split up here. The Leading cases tab lists the cases that cite it most heavily.

Enactment and amendments

Syfert holds no separate history line for this section. Where this code prints a source or history note, it appears with the text, usually at the end.

Versions

Edition shown: eCFR text as of Sept. 29, 2026. Syfert holds no earlier or later version of this section.

C.F.R. Home  |  Search C.F.R.  |  Search cases for this section  |  syfert.com